COMMUNIQUÉS West-GlobeNewswire

RedHill Biopharma Announces Enrollment of 300th Patient in Confirmatory Phase III Study with TALICIA® for H. pylori Infection

04/05/2018 - 13:00

Approximately 70% of the planned total of 444 patients have been enrolled in the ongoing confirmatory U.S. Phase III study with TALICIA ® for H. pylori infection (ERADICATE Hp2) RedHill expects to complete enrollment in [...]

Auris Medical Announces Publication Related to AM-111 in Peer-Reviewed Scientific Journal

04/05/2018 - 12:45

Zug, Switzerland, May 4, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today announced the [...]

Achillion to Present at the Deutsche Bank 43rd Annual Health Care Conference

04/05/2018 - 12:35

NEW HAVEN, Conn., May 04, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN ) announced today that Joseph Truitt, President and Chief Executive Officer of Achillion, will present a corporate [...]

Sernova Announces Results of 2018 Annual General Meeting of Shareholders and New Chief Financial Officer

04/05/2018 - 12:00

Shareholder approval of all management resolutions at AGM; CEO announces new Biotech CFO with strong North America capital market experience LONDON, Ontario, May 04, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V: SVA [...]

OraSure Technologies Appoints New Chief Financial Officer

04/05/2018 - 12:00

BETHLEHEM, Pa., May 04, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Roberto Cuca has been [...]

HMS Holdings Corp. Reports First Quarter 2018 Results

04/05/2018 - 12:00

GAAP EPS of $0.07 Per Diluted Share Adjusted EPS of $0.22 Per Diluted Share Total Revenue was $141.4 Million, Including an $8.4 Million Medicare RAC Reserve Release Payment Integrity Revenue of $28.7 Million was Up [...]

Immutep to Present at 2018 ASCO Annual Meeting

04/05/2018 - 10:00

SYDNEY, Australia, May 04, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (Immutep or the Company) today announced that it will present posters during the 2018 American Society for Clinical Oncology [...]

Align Technology Opens Invisalign® Treatment Planning and Training Facility in Germany

04/05/2018 - 10:00

Investment Reflects Large, Untapped Market Opportunity for Clear Aligners and Commitment to the Region COLOGNE, Germany and SAN JOSE, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN ), [...]

Vistin Pharma ASA : Recommendation from the Election Committee

04/05/2018 - 09:46

Reference is made to the call for the annual general meeting to be held on 8 May 2018. Please find attached the recommendation from the Election Committee. The document will also be made available on www.vistin.com . [...]

Shire plc : Rule 2.9 announcement

04/05/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 4 May 2018 Shire [...]

Immunicum AB (publ) Interim report January - March 2018

04/05/2018 - 08:01

Press Release 4 May 2018 Immunicum AB (publ) Interim report January - March 2018 Significant Events During the First Quarter Patient recruitment was completed for the ongoing, global Phase II MERECA (MEtasatic REnal [...]

Three-month interim report (Q1) 2018

04/05/2018 - 07:35

Performance for the period (unaudited) Financial results in Q1 were better than expected and as a result, ALK has improved its full-year financial outlook. Q1 saw good progress with ALK’s four strategic priorities which [...]

Nicox : Point d'activité du premier trimestre 2018 et résultats financiers

04/05/2018 - 07:31

Communiqué de presse Nicox : Point d'activité du premier trimestre 2018 et résultats financiers ............................................. 4 mai 2018 - diffusion à 7h30 Sophia Antipolis, France Nicox S.A. (Euronext [...]

Nicox Provides First Quarter 2018 Business and Financial Results

04/05/2018 - 07:31

Press Release Nicox Provides First Quarter 2018 Business and Financial Results .............................................. May 4, 2018 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: [...]

Bone Therapeutics Business Update for First Quarter 2018

04/05/2018 - 07:01

Regulated information / Press release Bone Therapeutics Business Update for First Quarter 2018 Patient recruitment completed for the Phase IIA lumbar spinal fusion study with ALLOB ® Board strengthened with appointments [...]

Bone Therapeutics publie son rapport d'activité du premier trimestre 2018

04/05/2018 - 07:01

Information réglementée / Communiqué de presse Bone Therapeutics publie son rapport d'activité du premier trimestre 2018 Fin du recrutement dans l'étude de Phase IIA en fusion vertébrale avec ALLOB ® Nomination de Jean [...]

Bone Therapeutics SA : Information on the total number of voting rights and shares

04/05/2018 - 07:01

Regulated information Information on the total number of voting rights and shares Gosselies, Belgium, 4 May 2018, 7am CET - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company [...]

Bone Therapeutics SA : Information relative au nombre total de droits de vote et d'actions

04/05/2018 - 07:01

Information réglementée Information relative au nombre total de droits de vote et d'actions Gosselies, Belgique, le 4 mai 2018, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de [...]

U.S. FDA Approves Portola Pharmaceuticals’ Andexxa®, First and Only Antidote for the Reversal of Factor Xa Inhibitors

04/05/2018 - 03:49

– Breakthrough Product is a Major Advance in the Treatment of Patients Hospitalized with Life-Threatening Bleeding – – Company to Host Conference Call on Friday, May 4, 2018 at 8:30 a.m. ET – SOUTH SAN FRANCISCO, Calif [...]